...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists.
【24h】

Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists.

机译:新的δ2-异恶唑啉衍生物的合成及其作为β-肾上腺素能受体拮抗剂的药理学表征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of delta 2-isoxazoline derivatives structurally related to Broxaterol 1 and Falintolol 3 has been prepared and evaluated for their binding affinity to beta 1- and beta 2-adrenergic receptors. Among the tested compounds only the 3-isopropenyl anti derivative 4d is as active as the reference compounds. An electron-releasing group, probably operating through a pi-pi interaction, in the 3-position of the isoxazoline nucleus greatly enhances the affinity of the compounds. Conversely, the closest analogs of Broxaterol (3-bromo delta 2-isoxazolines 4a and 5a) are at least one order of magnitude less active than the model compound 1. Throughout the series of derivatives the anti stereoisomers are invariably more active than their syn counterparts.
机译:已经制备了一系列与溴苯特罗1和氟林醇3结构相关的δ2-异恶唑啉衍生物,并评估了它们与β1和β2肾上腺素受体的结合亲和力。在所测试的化合物中,仅3-异丙烯基抗衍生物4d具有与参考化合物相同的活性。异恶唑啉核的3-位上可能通过pi-pi相互作用起作用的电子释放基团极大地增强了化合物的亲和力。相反,最接近的溴苯特罗类似物(3-溴代δ2-异恶唑啉4a和5a)的活性比模型化合物1低至少一个数量级。在一系列衍生物中,抗立体异构体的活性始终比其同系对应物高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号